Keywords: immunex, drops, plans, develop, enbrel, crohn, disease

Immunex drops plans to develop Enbrel for Crohn's disease

Article | 14 February 2001

Immunex has decided not to press ahead with the development of itsanti-tumor necrosis factor drug Enbrel (etanercept) as a treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in